6,7,8-trimethoxycoumarin,
Dimethylfraxetin,
6,7,8-Trimethoxycoumarin,
6035-49-0,
6,7,8-Trimethoxy-2H-chromen-2-one,
Fraxidin Methyl Ether,
6,7,8-trimethoxychromen-2-one,
6,7,8,-trimethoxycoumarin,
CHEMBL253551,
Fraxetin dimethyl ether,
KBio1_001126,
Spectrum_000635,
SpecPlus_000086,
2H-Benzopyran-2-one, 6,7,8-trimethoxy-,
AC1MJ1KJ,
Spectrum2_000357,
Spectrum3_000111,
Spectrum4_001392,
Spectrum5_000124,
2H-1-Benzopyran-2-one, 6,7,8-trimethoxy-,
BSPBio_001722,
KBioGR_001744,
KBioSS_001115,
SPECTRUM100572,
DivK1c_006182,
SPBio_000453,
SCHEMBL2464275,
CHEBI:93172,
CTK8J5557,
KBio2_001115,
KBio2_003683,
KBio2_006251,
KBio3_000862,
DTXSID00209112,
RAYQKHLZHPFYEJ-UHFFFAOYSA-N,
HY-N0085,
ZINC2516970,
BDBM50428439,
CCG-38632,
AKOS016009536,
CS-7783,
MCULE-3556464581,
SDCCGMLS-0066335.P001,
NCGC00095436-01,
NCGC00095436-02,
NCGC00179059-01,
4CN-1209,
AJ-37007,
AK111287,
FT-0688280,
N2285,
ST24044980,
ST50331488,
W1279,
A14655,
C-56613,
SR-05000002478,
SR-05000002478-1,
BRD-K66944906-001-01-8,
NCGC00095436-04!6,7,8-trimethoxychromen-2-one,
InChI=1/C12H12O5/c1-14-8-6-7-4-5-9(13)17-10(7)12(16-3)11(8)15-2/h4-6H,1-3H,
Di-O-methylfraxetin,
Coumarin, 6,7,8-trimethoxy-,
C12H12O5,
ACN-047377,
C12-H12-O5,
CID3083928,